HPA038497

antibody from Atlas Antibodies

Targeting: KANSL2 C12orf41, FLJ20436, NSL2

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

HPA038497

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA038497, RRID:AB_10674685

Product name

Anti-KANSL2

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human KANSL2, Gene description: KAT8 regulatory NSL complex subunit 2, Alternative Gene Names: C12orf41, FLJ20436, NSL2, Validated applications: IHC, Uniprot ID: Q9H9L4, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Ropivacaine represses the proliferation, invasion, and migration of glioblastoma via modulating the microRNA-21-5p/KAT8 regulatory NSL complex subunit 2 axis

Deng Z, Jian Y, Cai H
Bioengineered 2022;13(3):5975-5986

---

Evolutionary conserved NSL complex/BRD4 axis controls transcription activation via histone acetylation

Gaub A, Sheikh B, Basilicata M, Vincent M, Nizon M, Colson C, Bird M, Bradner J, Thevenon J, Boutros M, Akhtar A
Nature Communications 2020;11(1)

---

The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem–like Properties in Glioblastoma That Contribute to Tumorigenesis

Ferreyra Solari N, Belforte F, Canedo L, Videla-Richardson G, Espinosa J, Rossi M, Serna E, Riudavets M, Martinetto H, Sevlever G, Perez-Castro C
Cancer Research 2016;76(18):5383-5394